Generated by GPT-5-mini| Consortium for Innovation and Entrepreneurship | |
|---|---|
| Name | Consortium for Innovation and Entrepreneurship |
| Abbreviation | CIE |
| Formation | 2010 |
| Type | Nonprofit consortium |
| Headquarters | Boston, Massachusetts |
| Region served | United States; international partners |
| Leader title | Executive Director |
| Leader name | Dr. Amelia Rowan |
Consortium for Innovation and Entrepreneurship is a collaborative network formed to accelerate technology transfer, venture formation, and regional development through coordinated programs between universities, corporations, and public institutions. It convenes stakeholders from academia, industry, philanthropy, and municipal agencies to support startups, commercialization, and workforce development. The consortium emphasizes cross-sector collaboration, translational research, and policy engagement to scale innovation clusters and entrepreneurship ecosystems.
The consortium emerged from a 2009 convening that included delegations from Massachusetts Institute of Technology, Harvard University, University of California, Berkeley, Stanford University, University of Michigan, and representatives from National Science Foundation, Department of Commerce (United States), and the Kauffman Foundation. Early pilot projects drew on models from Silicon Valley, Route 128, Research Triangle Park, and Cambridge, England innovation districts, influenced by studies from Brookings Institution, RAND Corporation, and the World Economic Forum. Founding members included leaders from General Electric, IBM, Google, Microsoft, Intel, and philanthropic support from The Rockefeller Foundation and Gordon and Betty Moore Foundation. Major milestones incorporated partnerships with Small Business Administration, collaborations with Massachusetts Technology Collaborative, and policy briefings for the United States Congress and the European Commission.
The consortium's mission aligns with objectives advocated by National Institutes of Health translational initiatives, Defense Advanced Research Projects Agency-style rapid prototyping, and the commercialization strategies of Y Combinator and 500 Startups. Objectives include accelerating licensing pipelines between Columbia University, Yale University, and regional incubators; increasing spinouts modeled on Oxford University Innovation and Cambridge Enterprise; and supporting cluster development similar to Biotech Bay Area and Boston-Cambridge life sciences hubs. It also aims to inform policy discussions in forums such as G20 innovation working groups, Organisation for Economic Co-operation and Development panels, and municipal innovation strategies exemplified by City of Boston and City of San Francisco.
Governance follows a board model with representation from partner institutions including Princeton University, Brown University, Cornell University, Duke University, Johns Hopkins University, and major corporate members such as Pfizer, Biogen, Moderna, Novartis, and Johnson & Johnson. An executive office led by an executive director works with program directors overseeing units for technology transfer, startup acceleration, policy advocacy, and workforce training, liaising with offices like MIT Technology Licensing Office, Stanford Office of Technology Licensing, and UC Berkeley Office of Technology Licensing. Advisory committees include leaders from Silicon Valley Bank, Goldman Sachs, Sequoia Capital, Andreessen Horowitz, and legal partners patterned after firms like Skadden, Arps, Slate, Meagher & Flom.
Flagship programs mirror models from MassChallenge, Techstars, and Plug and Play Tech Center, offering accelerated cohorts, proof-of-concept grants, and cohort-based mentorship. Initiatives include a university spinout incubator working with Imperial College London and ETH Zurich; a biotech translation accelerator in collaboration with Broad Institute and Dana-Farber Cancer Institute; a clean-energy commercialization track informed by National Renewable Energy Laboratory research and Tesla-adjacent industry practices; and a social innovation lab partnering with Ashoka and Schwab Foundation for Social Entrepreneurship. Programs also run policy fellowships modeled on Presidential Innovation Fellows and workforce pipelines inspired by Year Up and ApprenticeshipUSA.
Membership spans higher education, private sector, philanthropy, and municipal agencies, including ties to University of Pennsylvania, University of Chicago, Northwestern University, Arizona State University, University of Texas at Austin, and international partners such as Tsinghua University, National University of Singapore, University of Tokyo, Australian National University, and Tecnológico de Monterrey. Corporate alliances extend to Amazon, Apple Inc., Samsung, Siemens, BASF, and Shell. Strategic partners include World Bank, Inter-American Development Bank, European Investment Bank, and regional development agencies like MassDevelopment and Enterprise Ireland.
The consortium operates on a mixed funding model combining grants from foundations like Bill & Melinda Gates Foundation and Carnegie Corporation of New York, government awards from National Science Foundation and Economic Development Administration (EDA), membership dues from universities and corporations, and revenue from licensing, sponsored research with GlaxoSmithKline and Roche, and program fees. Venture funds co-managed with University Technology Fund-style vehicles and limited partners including Harvard Management Company and Yale Investments Office provide follow-on capital. Financial oversight follows compliance standards promoted by Council on Foundations and audit practices similar to Deloitte and Ernst & Young.
Reported outcomes parallel impact metrics used by Innovate UK and Startup Genome, including the number of startups launched, patents licensed with offices like USPTO, jobs created in clusters comparable to Silicon Fen and Biotech Boston, and follow-on investment from firms such as Bain Capital and BlackRock. Case studies highlight spinouts that partnered with Amgen, achieved exits via acquisitions by Google, Apple Inc., and Microsoft, or completed public offerings on exchanges like NASDAQ and New York Stock Exchange. Evaluations by independent analysts from McKinsey & Company, Boston Consulting Group, and IESE Business School indicate measurable increases in regional productivity, patent commercialization rates, and cross-border collaboration. Ongoing metrics track inclusive entrepreneurship outcomes referencing programs from Kiva and Accion.
Category:Nonprofit organizations based in the United States